2018
DOI: 10.1093/annonc/mdy271.267
|View full text |Cite
|
Sign up to set email alerts
|

CD8+, CD4+ and FOXP3+ cell profiles and their change after neoadjuvant chemotherapy in patients with triple negative breast cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…Mutations in the expression of the Foxp3 gene have been associated with tumorigenic activity [29,30]. The Tregulator cell Foxp3 has also emerged as a prognostic biomarker in breast cancer and its response to chemotherapy [31][32][33][34][35].…”
Section: Stress Sel Tregulator and Breast Cancermentioning
confidence: 99%
“…Mutations in the expression of the Foxp3 gene have been associated with tumorigenic activity [29,30]. The Tregulator cell Foxp3 has also emerged as a prognostic biomarker in breast cancer and its response to chemotherapy [31][32][33][34][35].…”
Section: Stress Sel Tregulator and Breast Cancermentioning
confidence: 99%
“…To be more specific, Ladoire et al ( 181 ) and Senovilla et al ( 182 ) found that, in patients treated with NAC, it is the increased CTL/Treg cell ratio in TME that can precisely predict pCR. Interestingly, the levels of CD8+ T cells and Tregs decreased during NAC in patients of TNBC ( 183 ), which raise a question of whether the dynamics of Treg can predict pCR. Hamy et al ( 179 ) found that the decrease of lymphocyte infiltration during chemotherapy is related to the increase of PCR rate, which may be related to the disappearance of Treg after neoadjuvant therapy, but there are few related studies.…”
Section: The Correlation Between Tregs and Different Therapeutic Strategies Of Bcmentioning
confidence: 99%